Dec 6 (Reuters) - Cochlear Ltd (COH) :
- UK'S COMPETITION AND MARKETS AUTHORITY SAYS MERGER OF 2 LEADING PROVIDERS OF HEARING IMPLANTS COULD LEAD TO HIGHER PRICES FOR NHS, AND REDUCED QUALITY AND SLOWER INNOVATION FOR UK PATIENTS WHO RELY ON THESE LIFE-CHANGING DEVICES.
- UK'S COMPETITION AND MARKETS AUTHORITY SAYS IS CONCERNED THAT COCHLEAR'S PROPOSED PURCHASE OF OTICON MEDICAL - HEARING IMPLANT DIVISION OF DEMANT -WOULD HAVE A NEGATIVE IMPACT ON PATIENTS WHO NEED HEARING IMPLANTS
- UK'S COMPETITION AND MARKETS AUTHORITY SAYS COCHLEAR AND DEMANT NOW HAVE UNTIL 13 DECEMBER 2022 TO ADDRESS CMA'S CONCERNS THROUGH OFFER OF UNDERTAKINGS.
News: COH UK's competition watchdog flags concerns over Demant, Cochlear deal
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$318.40 |
Change
5.570(1.78%) |
Mkt cap ! $20.72B | |||
| Open | High | Low | Value | Volume |
| $314.28 | $318.72 | $313.71 | $6.106M | 19.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 34 | $318.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $318.43 | 47 | 8 |
View Market Depth
| Last trade - 11.23am 28/07/2025 (20 minute delay) ? |
| COH (ASX) Chart |